Dimensional Fund Advisors LP Lowers Stock Position in LENSAR, Inc. (NASDAQ:LNSR)

Dimensional Fund Advisors LP decreased its holdings in LENSAR, Inc. (NASDAQ:LNSR - Free Report) by 5.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 614,384 shares of the company's stock after selling 34,575 shares during the quarter. Dimensional Fund Advisors LP owned 5.29% of LENSAR worth $5,492,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of LNSR. Evernest Financial Advisors LLC acquired a new position in shares of LENSAR in the 4th quarter valued at approximately $174,000. Bailard Inc. bought a new stake in LENSAR during the 4th quarter worth approximately $181,000. Atria Investments Inc lifted its position in shares of LENSAR by 28.2% in the 4th quarter. Atria Investments Inc now owns 26,055 shares of the company's stock worth $233,000 after purchasing an additional 5,729 shares during the period. Essex Investment Management Co. LLC lifted its position in shares of LENSAR by 18.3% during the 4th quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company's stock valued at $357,000 after acquiring an additional 6,184 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of LENSAR by 3.5% during the 3rd quarter. Geode Capital Management LLC now owns 100,431 shares of the company's stock valued at $460,000 after acquiring an additional 3,423 shares during the period. Institutional investors and hedge funds own 40.15% of the company's stock.

LENSAR Stock Performance

LNSR traded down $0.01 on Friday, reaching $14.11. The company had a trading volume of 57,272 shares, compared to its average volume of 75,857. The business has a 50 day simple moving average of $14.14 and a 200 day simple moving average of $10.81. The company has a market cap of $166.39 million, a price-to-earnings ratio of -9.66 and a beta of 0.56. LENSAR, Inc. has a 52-week low of $3.50 and a 52-week high of $17.31.

LENSAR (NASDAQ:LNSR - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported ($2.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($2.16). The firm had revenue of $11.53 million during the quarter, compared to the consensus estimate of $13.40 million. LENSAR had a negative return on equity of 49.02% and a negative net margin of 34.03%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on LNSR. BTIG Research downgraded shares of LENSAR from a "strong-buy" rating to a "hold" rating in a report on Monday, March 24th. Lake Street Capital restated a "hold" rating and set a $15.00 price target (down previously from $16.00) on shares of LENSAR in a research report on Monday, March 24th.

LENSAR Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.